source clustersSource Clusters is the single source of information on regional development in the life sciences sector worldwide.

With content providing broad overviews as well as in-depth coverage of business development trends, company activities, life science cluster collaborations, multi-partner scientific projects and its extensive news coverage, Source Clusters presents the latest management, research, technology and regional development information serving the needs of executives in the internationally growing life sciences sector.

Source Clusters is the essential resource for companies, incubators, science parks, clusters and regional development agencies looking to find a new location or attract new business and exploit new opportunities across the life sciences sector.

Concept Life Sciences forms Scientific Advisory Board

Drug discovery and development specialist and analytical services company Concept Life Sciences has completed the formation of its Scientific Advisory Board (SAB) for the drug discovery and development side of the business. The members are leading experts in a diverse…

Sangamo finalises TxCell acquisition

Sangamo Therapeutics, Inc. has completed its acquisition of TxCell, SA, which has been delisted from the French stock market. “The acquisition of TxCell immediately positions Sangamo as the leader in CAR-Treg development,” said Sandy Macrae, CEO of Sangamo. “By combining…

MaSTherCell doubles production capacity

Cell therapy-dedicated CDMO MaSTherCell SA has opened a new 600 sq m production wing at its site in Belgium. The expansion of the plant will provide the company with five additional state-of-the-art late-stage and commercially-ready cleanrooms. The new wing has…

Absolute Antibody expands production facilities

Antibody specialist Absolute Antibody Ltd has opened a major new expansion to its site in north-east England. The company opened a production facility in the area just two years after it was founded in Oxford in 2012, and now provides…

Battery Ventures acquires TTP Labtech

TTP Labtech Ltd, which specialises in the design and development of automated instrumentation and consumables for life science research, has been acquired by Battery Ventures as part of TTP Group’s decision to divest TTP Labtech to allow the company to…

Avacta agrees Affimer reagent licensing deal with New England Biolabs

Avacta Group plc, the developer of Affimer biotherapeutics and reagents, has agreed a commercial licence with Ipswich, Massachusetts, USA based New England Biolabs (NEB), a company specialising in the discovery and production of enzymes for molecular biology applications, to commercialise…

Evonetix partners with LioniX International to enable DNA synthesis at scale

Evonetix, a Cambridge, UK-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, and LioniX International, a global provider of customised microsystem solutions in scalable production volumes, will collaborate to scale up production of prototype microelectromechanical systems (MEMs)…

Owlstone Medical completes $50 million financing

Diagnostics company Owlstone Medical Ltd, which is developing a breathalyser for applications in early disease detection and precision medicine, has completed its financing round to drive the global commercialisation of its Breath Biopsy platform. The round raised a total of…
Subscribe to this RSS feed